The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease ...

One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They found that the drug slowed cognitive decline by 46% in a group of patients ...

A man with one of the deadliest forms of brain cancer is now hopeful for the future after his tumor completely disappeared ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

Participants in trials of BrainStorm Cell Therapeutics' NurOwn filed a Citizens’ Petition with the FDA earlier this month ...

Health professionals and advocates shared experiences and insights on the critical importance of Black participation in ...

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

For patients unable to withstand the increased toxicity of a four-drug regimen, the two most commonly used triplet regimens ...

The administration said it is fast-tracking clinical trials that would allow patients struggling with serious mental health ...